5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Advanced Solid Tumors - Contacts and Locations

5-Fluoro-2'-Deoxycytidine and Tetrahydrouridine in Treating Patients With Advanced Solid Tumors

This study is currently recruiting participants.

Study NCT00378807. Last updated on October 18, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00378807

Locations


United States, California
	City of Hope Comprehensive Cancer Center	Recruiting
	Duarte, California, United States, 91010-3000
	Contact: Clinical Trials Office - City of Hope Comprehensive Cancer Cen 800-826-4673 becomingapatient@coh.org
	University of California Davis Cancer Center	Recruiting
	Sacramento, California, United States, 95817
	Contact: Clinical Trials Office - University of California Davis Cancer 916-734-3089
	USC/Norris Comprehensive Cancer Center and Hospital	Recruiting
	Los Angeles, California, United States, 90089-9181
	Contact: Clinical Trials Office - USC/Norris Comprehensive Cancer Cente 323-865-0451

United States, Maryland
	Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office	Recruiting
	Bethesda, Maryland, United States, 20892-1182
	Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937

Sponsors and Collaborators

NCI - Center for Cancer Research-Medical Oncology

Investigators


Principal Investigator:	James H. Doroshow, MD	National Cancer Institute (NCI)